stay updated with our newsletter

Cannabidiol Offers Inflammatory Properties for Contact Dermatitis

This study is the first demonstration of the anti-inflammatory properties of Cannabidiol in an experimental model for allergic contact dermatitis (ACD). Published in the J. Pharmacology and Experimental Therapeutics, March 2018. Abstract / Phytocannabinoids modulate inflammatory responses by regulating the production of cytokines in several experimental models of inflammation. Cannabinoid type-2Read

Breast Cancer Joins Pain as Conditions with Dominant School Endorsement of Integrative Strategies

The movement of medicine toward an integrative model took an important step in early June. The American Society of Clinical Oncology (ASCO) endorsed a clinical practice guideline for integrative therapies during and after breast cancer treatment. The endorsement was published on June 11, 2018 in ASCO’s Journal of Clinical Oncology as “Integrative TherapiesRead

Free On-Demand Webinar on Supporting Mood Disorders with Scot Bay, MD and Jane Foster, PhD

Popular contributors Scot Bay, MD  and Jane Foster, PhD are back with a ready-watch webinar on animal science and clinical research that explains the gut-brain axis and how specific probiotic strains can positively support mood and mental health. Dr. Bay will elaborate on his case studies using probiotic formulas asRead

Finding Emotional Balance with Your Patients, Interview with Leslie Korn, PhD., Author Good Mood Kitchen

The Good Mood Kitchen

In light of recent tragic events with fashion designer Kate Spade and celebrity chef Anthony Bourdain and a growing number of suicides in Western society, it’s important to remember that whole health wellness plays a crucial role in addressing mental health and mood disorders. One part of that care isRead

Bacteriophages: The Next Gut Friendly Antibiotic Replacement

At last week’s Nutrition 2018 conference in Boston, scientists from the Department of Nutrition and Food Studies at George Mason University in Fairfax, VA released an exciting new study showing the  therapeutic potential of bacteriophages. The Bacteriophage for Gastrointestinal Health (PHAGE) Study is the first randomized, double-blind, placebo controlled cross-overRead

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.